These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 35497783)

  • 1. Management of Hypertension in Patients With Diabetic Kidney Disease: Summary of the Joint Association of British Clinical Diabetologists and UK Kidney Association (ABCD-UKKA) Guideline 2021.
    Banerjee D; Winocour P; Chowdhury TA; De P; Wahba M; Montero R; Fogarty D; Frankel A; Goldet G; Karalliedde J; Mark PB; Patel D; Pokrajac A; Sharif A; Zac-Varghese S; Bain S; Dasgupta I;
    Kidney Int Rep; 2022 Apr; 7(4):681-687. PubMed ID: 35497783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of hypertension and renin-angiotensin-aldosterone system blockade in adults with diabetic kidney disease: Association of British Clinical Diabetologists and the Renal Association UK guideline update 2021.
    Banerjee D; Winocour P; Chowdhury TA; De P; Wahba M; Montero R; Fogarty D; Frankel AH; Karalliedde J; Mark PB; Patel DC; Pokrajac A; Sharif A; Zac-Varghese S; Bain S; Dasgupta I;
    BMC Nephrol; 2022 Jan; 23(1):9. PubMed ID: 34979961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical practice guideline for the management of lipids in adults with diabetic kidney disease: abbreviated summary of the Joint Association of British Clinical Diabetologists and UK Kidney Association (ABCD-UKKA) Guideline 2024.
    Zac-Varghese S; Mark P; Bain S; Banerjee D; Chowdhury TA; Dasgupta I; De P; Fogarty D; Frankel A; Goldet G; Karalliedde J; Mallik R; Montero R; Sharif A; Wahba M; Dhatariya K; McCafferty K; Lioudaki E; Winocour P
    BMC Nephrol; 2024 Jul; 25(1):216. PubMed ID: 38971750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical practice guidelines for management of hyperglycaemia in adults with diabetic kidney disease.
    Karalliedde J; Winocour P; Chowdhury TA; De P; Frankel AH; Montero RM; Pokrajac A; Banerjee D; Dasgupta I; Fogarty D; Sharif A; Wahba M; Mark PB; Zac-Varghese S; Patel DC; Bain SC
    Diabet Med; 2022 Apr; 39(4):e14769. PubMed ID: 35080257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Finerenone: A Potential Treatment for Patients with Chronic Kidney Disease and Type 2 Diabetes Mellitus.
    D'Marco L; Puchades MJ; Gandía L; Forquet C; Giménez-Civera E; Panizo N; Reque J; Juan-García I; Bermúdez V; Gorriz JL
    touchREV Endocrinol; 2021 Nov; 17(2):84-87. PubMed ID: 35118452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic kidney disease in type 2 diabetes: Implications for managing glycaemic control, cardiovascular and renal risk.
    Stephens JW; Brown KE; Min T
    Diabetes Obes Metab; 2020 Apr; 22 Suppl 1():32-45. PubMed ID: 32267078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sodium-glucose cotransporter-2 inhibitors and non-steroidal mineralocorticoid receptor antagonists: Ushering in a new era of nephroprotection beyond renin-angiotensin system blockade.
    Shenoy SV; Nagaraju SP; Bhojaraja MV; Prabhu RA; Rangaswamy D; Rao IR
    Nephrology (Carlton); 2021 Nov; 26(11):858-871. PubMed ID: 34176194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mineralocorticoid Antagonism and Diabetic Kidney Disease.
    Lytvyn Y; Godoy LC; Scholtes RA; van Raalte DH; Cherney DZ
    Curr Diab Rep; 2019 Jan; 19(1):4. PubMed ID: 30673886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetic kidney disease: a report from an ADA Consensus Conference.
    Tuttle KR; Bakris GL; Bilous RW; Chiang JL; de Boer IH; Goldstein-Fuchs J; Hirsch IB; Kalantar-Zadeh K; Narva AS; Navaneethan SD; Neumiller JJ; Patel UD; Ratner RE; Whaley-Connell AT; Molitch ME
    Am J Kidney Dis; 2014 Oct; 64(4):510-33. PubMed ID: 25257325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and Safety of Dual Blockade of the Renin-Angiotensin-Aldosterone System in Diabetic Kidney Disease: A Meta-Analysis.
    Feng Y; Huang R; Kavanagh J; Li L; Zeng X; Li Y; Fu P
    Am J Cardiovasc Drugs; 2019 Jun; 19(3):259-286. PubMed ID: 30737754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GLP-1 Receptor Agonists and Diabetic Kidney Disease: A Call of Attention to Nephrologists.
    Górriz JL; Soler MJ; Navarro-González JF; García-Carro C; Puchades MJ; D'Marco L; Martínez Castelao A; Fernández-Fernández B; Ortiz A; Górriz-Zambrano C; Navarro-Pérez J; Gorgojo-Martinez JJ
    J Clin Med; 2020 Mar; 9(4):. PubMed ID: 32235471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetic kidney disease treatment: new perspectives.
    Tong LL; Adler SG
    Kidney Res Clin Pract; 2022 Sep; 41(Suppl 2):S63-S73. PubMed ID: 36239062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renin-angiotensin system blockers-SGLT2 inhibitors-mineralocorticoid receptor antagonists in diabetic kidney disease: A tale of the past two decades!
    Singh AK; Singh R
    World J Diabetes; 2022 Jul; 13(7):471-481. PubMed ID: 36051422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-steroidal mineralocorticoid antagonists: Prospects for renoprotection in diabetic kidney disease.
    Al Dhaybi O; Bakris GL
    Diabetes Obes Metab; 2020 Apr; 22 Suppl 1():69-76. PubMed ID: 32267074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The 2021-2022 position of Brazilian Diabetes Society on diabetic kidney disease (DKD) management: an evidence-based guideline to clinical practice. Screening and treatment of hyperglycemia, arterial hypertension, and dyslipidemia in the patient with DKD.
    de Sá JR; Rangel EB; Canani LH; Bauer AC; Escott GM; Zelmanovitz T; Bertoluci MC; Silveiro SP
    Diabetol Metab Syndr; 2022 Jun; 14(1):81. PubMed ID: 35690830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renin-Angiotensin-Aldosterone System Blockade in Diabetic Nephropathy. Present Evidences.
    Lozano-Maneiro L; Puente-García A
    J Clin Med; 2015 Nov; 4(11):1908-37. PubMed ID: 26569322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lifestyle Modifications and Nutritional and Therapeutic Interventions in Delaying the Progression of Chronic Kidney Disease: A Review.
    Alkhatib L; Velez Diaz LA; Varma S; Chowdhary A; Bapat P; Pan H; Kukreja G; Palabindela P; Selvam SA; Kalra K
    Cureus; 2023 Feb; 15(2):e34572. PubMed ID: 36874334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multidisciplinary management of diabetic kidney disease: a systematic review and meta-analysis.
    Helou N; Dwyer A; Shaha M; Zanchi A
    JBI Database System Rev Implement Rep; 2016 Jul; 14(7):169-207. PubMed ID: 27532796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Present and future directions in diabetic kidney disease.
    Limonte CP; Kretzler M; Pennathur S; Pop-Busui R; de Boer IH
    J Diabetes Complications; 2022 Dec; 36(12):108357. PubMed ID: 36403478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic Advances in Diabetic Nephropathy.
    Sawaf H; Thomas G; Taliercio JJ; Nakhoul G; Vachharajani TJ; Mehdi A
    J Clin Med; 2022 Jan; 11(2):. PubMed ID: 35054076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.